A Food and Drug Administration (FDA) advisory panel has approved an epinephrine nasal spray, clearing a hurdle for the product designed to help those with severe, potentially life-threatening allergic reactions. The panel, the Pulmonary-Allergy Drugs Advisory Committee, voted 17-5 on Thursday to support the approval of Neffy, a spray that would give users a 2-milligram dose to treat allergic reactions including anaphylaxis as an alternative to an injection with a needle. The allergic reactions that Neffy can treat result from food, insect bites or stings, drugs, serum, diagnostic testing substances and other allergens, according to the briefing document for the drug for the commit
Hence then, the article about fda advisers clear hurdle for epinephrine nasal spray was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( FDA advisers clear hurdle for epinephrine nasal spray )